Identification of genes with abnormal expression changes in acute myeloid leukemia.

作者: Derek L. Stirewalt , Soheil Meshinchi , Kenneth J. Kopecky , Wenhong Fan , Era L. Pogosova-Agadjanyan

DOI: 10.1002/GCC.20500

关键词:

摘要: Acute myeloid leukemia (AML) is one of the most common and deadly forms hematopoietic malignancies. We hypothesized that microarray studies could identify previously unrecognized expression changes occur only in AML blasts. were particularly interested those genes with increased AML, believing these may be potential therapeutic targets. To test this hypothesis, we compared gene profiles between normal cells from 38 healthy donors leukemic blasts 26 patients. Normal samples included CD34+ selected (N = 18), unselected bone marrows 10), peripheral bloods 10). Twenty displayed AML-specific not found cells. Subsequent analyses using data 285 additional patients confirmed for 13 20 genes. Seven (BIK, CCNA1, FUT4, IL3RA, HOMER3, JAG1, WT1) while 6 (ALDHA1A, PELO, PLXNC1, PRUNE, SERPINB9, TRIB2) decreased expression. Quantitative RT/PCR 7 over-expressed performed an independent set 9 21 pediatric samples. All to normals. Three (WT1, IL3RA) have already been linked leukemogenesis and/or prognosis, little known about role other 4 AML. Future will determine their clinical significance.

参考文章(95)
Chittenden T, Avery Bj, Subramanian T, Gallo Gj, Houghton Ab, Boyd Jm, Ebb Rg, Malstrom S, Elangovan B, Lutz Rj, Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. ,vol. 11, pp. 1921- 1928 ,(1995)
Winifred M. Watkins, Julia L. Clarke, The genetic regulation of fucosylated and sialylated antigens on developing myeloid cells. Advances in Experimental Medicine and Biology. ,vol. 491, pp. 231- 265 ,(2001) , 10.1007/978-1-4615-1267-7_17
Lothar Bergmann, Cornelius Miething, Ulrich Maurer, Jürgen Brieger, Tunca Karakas, Eckhart Weidmann, Dieter Hoelzer, High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome Blood. ,vol. 90, pp. 1217- 1225 ,(1997) , 10.1182/BLOOD.V90.3.1217
K Inoue, H Sugiyama, H Ogawa, M Nakagawa, T Yamagami, H Miwa, K Kita, A Hiraoka, T Masaoka, K Nasu, WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. ,vol. 84, pp. 3071- 3079 ,(1994) , 10.1182/BLOOD.V84.9.3071.3071
Gregg Duester, Families of retinoid dehydrogenases regulating vitamin A function FEBS Journal. ,vol. 267, pp. 4315- 4324 ,(2000) , 10.1046/J.1432-1327.2000.01497.X
David Grimwade, Helen Walker, Fiona Oliver, Keith Wheatley, Christine Harrison, Georgina Harrison, John Rees, Ian Hann, Richard Stevens, Alan Burnett, Anthony Goldstone, The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial Blood. ,vol. 92, pp. 2322- 2333 ,(1998) , 10.1182/BLOOD.V92.7.2322
Alvis Brazma, Pascal Hingamp, John Quackenbush, Gavin Sherlock, Paul Spellman, Chris Stoeckert, John Aach, Wilhelm Ansorge, Catherine A. Ball, Helen C. Causton, Terry Gaasterland, Patrick Glenisson, Frank C.P. Holstege, Irene F. Kim, Victor Markowitz, John C. Matese, Helen Parkinson, Alan Robinson, Ugis Sarkans, Steffen Schulze-Kremer, Jason Stewart, Ronald Taylor, Jaak Vilo, Martin Vingron, Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature Genetics. ,vol. 29, pp. 365- 371 ,(2001) , 10.1038/NG1201-365
Alexander Gaiger, Valerie Reese, Mary L. Disis, Martin A. Cheever, Immunity to WT1 in the animal model and in patients with acute myeloid leukemia. Blood. ,vol. 96, pp. 1480- 1489 ,(2000) , 10.1182/BLOOD.V96.4.1480
Josep F. Nomdedeu, Mar Bellido, Salut Brunet, Anna Aventin, Olga Lopez, Maria J. Carnicer, Jorge Sierra, Luz Munoz, Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica. ,vol. 86, pp. 1261- 1269 ,(2001) , 10.3324/%X